About
Publications
Contact
 
Literary Resumé
 
Education
BA, Harvard College, 1962-1966
MD, Stanford Medical School, 1966-1971
Internship, Santa Clara Valley Medical Center, 1971-72
Residency in Ophthalmology, Stanford, 1972-1975
Fellowship in Ophthalmic Pathology, Walter Reed Army Medical Center, 1975-1977
Bread Loaf Writers’ Workshop, 1999, 2000, 2001

Employment
Department of Ophthalmology and Visual Sciences
University of Louisville School of Medicine
    Assistant Professor, 1977-1983
    Associate Professor, 1983-1992
    Professor, 1992-2001
    Professor Emeritus, 2001 – present

Academic Publications
95 articles and letters in a variety of refereed medical journals
Detailed listing available upon request

Essays Published or Accepted for Publication as of January 9th, 2008

Title Journal Citation
A Quiet Departure Boulevard Volume 62/63, P. 157
Those Who Will Not Be Healed Antioch Review Volume 64, No. 4, P. 799
Pendulous Love Boulevard Volume 65/66, P. 94
Spinal Beauty Gettysburg Review Volume 20, P. 425
Asphyxia Southern Humanities Review Volume 41, P. 241
Life in an Eggcup Alaska Quarterly Review Volume 24, P. 7
The Dark Mirror Shenandoah Volume 57, No. 2, P. 146
Hokum on the Rise Antioch Review Volume 66, No. 1, P. 130
The Bottom of the Pit Boulevard Volume 23, P. 70
Larry Beaten Epoch Volume 57, No. 1, P. 44
The Elegant Eye Alaska Quarterly Review Volume 6, Nos. 1 & 2, P. 55
The Funnel Epoch Volume 57, No. 3, P. 327
Dangerous Doctors Abaton In press
Death and the Maiden Abaton Issue 2, Fall 2008, P. 32
The Sleepers Gettysburg Review Volume 22, No. 1, P. 16
The Pluperfect Fraud Boulevard Volume 24, Nos. 2 & 3, P. 171
To sit or Not to Sit The Naked Scientist May 17, 2009


 
Scientific Resumé
 
Education
Fellowship
1975-1977
Ophthalmic Division, Armed Forces Institute of Ophthalmic Pathology, Walter Reed Army Medical Center, Washington, D.C.
Residency
Ophthalmology
1972-1975
Division of Ophthalmology; Stanford University Medical Center; Stanford, CA
Internship
Rotating
1971-1972
Santa Clara Valley Medical Center; San Jose, CA. (Affiliated with Stanford Medical School)
Medical School
Doctor of Medicine
1966-1971
Stanford Medical School; Stanford University; Stanford, CA
College
B.A. in Mathematics
1962-1966
Harvard College, Harvard University, Cambridge, MA

Positions Held
Assistant Professor, Ophthalmology
University of Louisville School of Medicine
10/1/77 through 6/30/83
Associate Professor, Ophthalmology
University of Louisville School of Medicine
7/1/83 through 7/1/92
Professor of Ophthalmology
University of Louisville School of Medicine
7/1/92 through 3/31/2001
Professor Emeritus
University of Louisville School of Medicine
3/31/01 through present

Certification
American Board of Ophthalmology, 1977

Licensure
California
1972 through 1975

District of Columbia, Virginia, and Maryland,
1975 through 1977

Kentucky
1977 to present; #19241

Special Interests
Diseases of the Retina
Ophthalmic Pathology
Ocular Malignancies
Cancer-Related Survival Analysis

Past and Present Memberships
American Academy of Ophthalmology
Kentucky Academy of Eye Physicians and Surgeons
Louisville Academy of Ophthalmology
Association for Research & Vision in Ophthalmology
American Association of Ophthalmic Pathologists
Georgiana Dvorak Theobold Society
Jefferson County Medical Society
Kentucky Medical Association
American Medical Association
ACB Study Committee
Membership Chairman of Cell Kinetics Society
Chairman of PCR Committee
President of UECEF Committee
U of L Compliance & Oversight Committee

Research Grants
Title: Classification of Uveal Melanomas
Source: Society for the Prevention of Blindness
Duration: 1978 through 1979
Total Direct Cost: $4,150.00

Title: Malignant Potential of Uveal Melanomas
Source: National Institutes of Health
Duration: 1979 through 1982
Total Direct Cost: $84,475.00

Renewed (same title) 1982 through 1985
Total Direct Cost: $172,229.00

Renewed (same title) 1985 through 1988
Total Direct Cost: $139,071.00

Title: Malignant Potential of Uveal Melanomas
Source: Veterans Administration
Duration: 1988 through 1991
Total Direct Cost: $657,199.00

Publications
1. Gamel JW, George SL, Edwards MJ, Seigler HF. The long-term course of patients with cutaneous melanoma. Cancer, Vol. 95, 2002: 1286-1293. 

2. Gamel JW, Bonadonna G, Valagussa P, Edwards MJ. Refined measurement of outcome for adjuvant breast carcinoma therapy. Cancer, Vol. 97, 2003: 1139-1146.

3. Gamel JW, Rousseau WF, Katholi CR, and Mesel E. Pitfalls in Digital Computation of the Impulse Response of Vascular Beds From Indicator-Dilution Curves. Circulation Research, Vol. 32, No. 4, 1973: 516-523.

4. Gamel JW and Allansmith M. Metastatic Endophthalmitis. Case Report and Review of the Literature. American Journal of Ophthalmology, Vol. 77, No. 4, 1974: 454-458.

5. Rao NA, Gamel JW, McMahom RT, and McLean IW. Correlation of In Vitro 32-P Counts with Histopathologic Features of Malignant Melanomas of Choroid and Ciliary Body. Investigative Ophthalmology, Vol. 16, No. 1, 1977: 98-102.

6. Gamel JW and McLean IW. Quantitative Analysis of Callender's Classification of Uveal Melanoma Cells. Archives of Ophthalmology, Vol. 95, No. 4, 1977: 686-691.

7. Gamel JW, McLean IW, and Foster WR. Uveal Melanomas: the Correlation of Cytologic Features With Prognosis. Cancer, Vol. 41, No. 5, 1978: 1897-1901.

8. Gamel JW and Font RL. Tumors of the Lacrimal Gland. Perspectives in Ophthalmology, Vol. 2, No. 2, 1978: 121-125.

9. Font RL and Gamel JW. Epithelial Tumors of the Lacrimal Gland: An Analysis of 265 Cases. (Book Chapter.) In Ocular and Adnexal Tumors, Aesculapius Publishing Co., Birmingham, Ala., 1978. Ed. by F. Jakobiec.

10. Gamel JW, McLean IW, and Zimmerman LE. Melanocytic Lesions of the Posterior Uvea: The Impact of New Pathologic Concepts in Prognosis and Management. (Book Chapter). In Ocular and Adnexal Tumors, Aesculapius Publishing Co., Birmingham, Ala., 1978. Ed. by F. Jakobiec.

11. Font RL and Gamel JW. Adenoid Cystic Carcinoma of the Lacrimal Gland. (Book Chapter.) A Clinicopathologic Study of 79 Cases. In Ocular Pathology Update, Masson Publishing USA, Inc., 1980. Ed. by Don H. Nicholson.

12. Beck RW, Gamel JW, Willcourt RJ and Berman G. Acute Ischemic Optic Neuropathy in Severe Pre-eclampsia. American Journal of Ophthalmology, 1980, Vol. 90: 342-346

13. Forrest JW, Gamel JW and Eiferman RA. Mirror Meningiomas. Neuro- ophthalmology, 1981, Vol. 2: 135-139

14. Gamel JW and Font RL. Adenoid Cystic Carcinoma of the Lacrimal Gland: The Clinical Significance of a Basaloid Histologic Pattern. Human Pathol, 1982, Vol. 13: 219-225

15. Gamel JW. VIII: Vascular Diseases of the Retina and Choroid. (Book Chapter.) Ophthalmology Basic and Clinical Science Course, ed. M.E. Smith, American Academy of Ophthalmology, San Francisco, 1982: 139-153.

16. Gamel JW. VX: Intraocular Tumors and Simulating Lesions. (Book Chapter.) Ophthalmology Basic and Clinical Science Course, ed. M.E. Smith, American Academy of Ophthalmology, San Francisco 1982: 155-175.

17. Gamel JW, McLean IW, Greenberg RA, Zimmerman LE, and Lichenstein SJ. Computerized Histopathologic Assessment of Malignant Potential: A Method for Determining the Prognosis of Uveal Melanomas. Human Pathol, Vol. 13, 1982: 893-97

18. Gamel JW and McLean IW. Computerized Histopathologic Assessment of Malignant Potential: II. A Practical Method For Predicting Survival Following Enucleation For Uveal Melanoma. Cancer, Vol. 52, 1983,: 1032-1038.

19. McLean IW, Foster WD, Zimmerman LE and Gamel JW. Modifications of Callender's Classification of Uveal Melanoma at the Armed Forces Institute of Pathology. Am J Ophthal, Vol. 96, 1983: 502-509.

20. Gamel JW and Eiferman RA. Corneal Burns and Cataracts Caused By Argon Laser Therapy With the Rodenstock Panfunduscopic Lens. Arch Ophthal, Vol. 101, 1983: 665.

21. Gamel JW and McLean IW. Computerized Histopathologic Assessment of Malignant Potential: III. Refinements of Measurement and Data Analysis. Analytical and Quantitative Cytology, Vol. 6, 1984: 37-44.

22. Gamel JW and McLean IW. Modern Developments in Histopathologic Assessment of Uveal Melanomas. Ophthalmol, Vol. 91, 1984: 679-684.

23. Gamel JW, Eiferman RA and Guibor P. Mucoepidermoid Carcinoma of the Conjunctiva. Arch Ophthalmol, Vol. 102, 1984: 730-731.

24. Gamel JW, McLean I, Greenberg RA, Naids RM, Folberg R, Donoso LA, Seddon JM and Albert DM. Objective Assessment of the Malignant Potential of Intraocular Melanomas With Standard Microslides Stained With Hematoxylin-eosin. Human Pathol, Vol. 16, 1985: 689-692.

25. Gamel JW, Gleason J, Williams H and Greenberg R. Reproducibility of Nucleolar Measurements in Human Intraocular Melanoma Cells on Standard Histologic Microslides. Anal Quant Cytol, Vol. 7, 1985:174-177. 

26. Markoe AM, Brady LW Jr., Shields JA, Augsburger JJ, Micaily B, Damsker JI, Day JL and Gamel JW. Malignant Melanoma of the Eye: Treatment of Posterior Uveal Lesions By Co-60 Plaque Radiotherapy Versus Enucleation. Radiology, Vol. 156, 1985: 801-803

27. Gamel JW. Ocular Melanoma (Letter to the Editor). Arch Ophthalmol, 1985, Vol 103: 1284.

28. Folberg R, Augsburger JJ, Gamel JW, Shields JA, and Lang WR. Fine-needle Aspirates of Uveal Melanomas and Prognosis. Am J Ophthalmol, Vol. 100, 1985: 654-657.

29. Augsburger JJ, Gamel JW, Bailey RS, et. al. Accuracy of Clinical Estimates of Tumor Dimensions: A Clinical-pathologic Correlation Study of Posterior Uveal Melanomas. Retina, Vol. 5, 1985: 26-29.

30. Folberg R, Gamel JW, Greenberg RA, Donoso LA, and Naids RM. Comparison of Direct and Microslide Pathology Measurements of Uveal Melanomas. Invest Ophthalmol Vis Sci, Vol. 26, 1985: 1788-1791.

31. Barr CC and Gamel JW. Blastomycosis of the Eyelid. Arch Ophthalmol, Vol. 104, 1986: 96-97.

32. Donoso LA, Augsburger JJ, Shields JA, Greenberg RA, and Gamel JW. Metastatic Uveal Melanoma: Correlation Between Survival Time and Cytomorphometry of Primary Tumors. Arch Ophthalmol, Vol. 104, 1986: 76-78.

33. Gamel JW, Greenberg RA, McLean IW, Seddon JM, Albert DM, Naids RE, Folberg R and Donoso LA. A Clinically Useful Method For Combining Gross and Microscopic Measurements to Select High-risk Patients After Enucleation For Ciliochoroidal Melanoma. Cancer, Vol. 57, 1986: 1341-1344.

34. Gamel JW, Seddon J, Polivogianis L, Albert D, and Greenberg R. A Method For Assessing Potential Bias Among Cancer Patients Recorded As "Dead of Other Causes." Cancer, Vol. 57, 1986: 2246-2249.

35. Augsburger JJ, Gamel JW, Sardi VF, Greenberg RA, Shields JA and Brady LW. Enucleation vs Cobalt Plaque Radiotherapy For Malignant Melanomas of the Choroid and Ciliary Body. Arch Ophthalmol, Vol. 104, 1986: 655-661.

36. Augsburger JJ, McNeary BT, VonBelow H, Gamel JW, et. al. Regression of Posterior Uveal Malignant Melanoma After Cobalt Plaque Radiotherapy. Graefe's Arch Clin Exp Ophthalmol, Vol. 224, 1986: 397-400.

37. McGraw C, Shields CB, Gamel JW and Greenberg RA. Impact of Cerebral Perfusion Pressure on Survival Following Head Trauma. Intracranial Pressure VI, Springer- Verlag, Berlin, 1986: 667-670.

38. Shapiro BE, Felberg NT, Donoso LA, Augsburger JJ, Shields JA and Gamel J. Flow Cytometry of Uveal Melanomas. Cancer Biochem Biophys, Vol. 8, 1986: 235-238.

39. Gamel JW, McLean IW and Greenberg R. Statistical Methods For the Practical Clinical Application of Morphometric Measurements. Analy & Quant Cytol, Vol. 9. 1987: 30-38.

40. Seddon JM, Polivogianis L, Hsieh C, Albert DM, Gamel JW, Evangelos S, and Gragoudas ES. Death From Uveal Melanoma: Number of Epithelioid Cells and Inverse S.D. of Nucleolar Area As Prognostic Factors. Arch Ophthalmol, Vol. 105, 1987: 801-806.

41. Augsburger JJ, Gamel JW, Shields JA, Markoe AM, and Brady LW. Post-irradiation Regression of Choroidal Melanomas as a Risk Factor for Death From Metastatic Disease. Ophthalmol, Vol. 94, 1987: 1173-1177.

42. Sanborn GE, Nguyen P, Gamel J, and Niederkorn JY. Reduction of Enucleation- Induced Metastasis in Intraocular Melanoma By Peri-enucleation Radiation. Arch Ophthalmol, Vol. 105, 1987: 1260-1264.

43. Niederkorn JY, Sanborn G, and Gamel JW. Suicide Enzyme Inhibition As a Chemotherapeutic Strategy For Controlling Metastasis Derived From Intraocular Melanomas. Invest Ophthalmol Vis Sci, Vol. 28, 1987: 1844-1850.

44. Gamel JW, McLean IW, and Greenberg RA. Interval-by-interval Cox Model Analysis of 3680 Cases of Intraocular Melanoma Shows a Decline In the Prognostic Value of Size and Cell Type Over Time After Tumor Excision. Cancer, Vol. 61, 1988: 574-579.

45. Gamel JW, Greenberg RA, and McLean IW. A Stable Linear Algorithm For Fitting the Lognormal Model to Survival Data. Comp Biomed Res, Vol. 28, 1988: 38-47.

46. McLean IW and Gamel JW. Prediction of Metastasis of Uveal Melanoma: Comparison of Morphometric Determination of Nucleolar Size and Spectrophotometric Determination of DNA. Investigative Ophthalmology & Visual Science, Vol. 29, 1988: 507-511.

47. Waters JA, Gamel JW, Keeney AH. Metastasis to the Eye and Ocular Adnexa. Cancer of the Breast, Edited by J. Spratt, 1988, 24: 664-669.

48. Gamel JW. Central Versus Peripheral Panretinal Photocoagulation. (Letter to the Editor). Ophthalmology, Vol. 95, 1988: 1157.

49. Gamel JW, McLean IW. A Method for Determining the Optimum Transform For Covariates of the Cox Model with Application to 3680 Cases of Intraocular Melanoma. Computers and Biomedical Research, Vol. 95, 1988: 471-477.

50. Gamel JW. Digital Dermatoglyphics in Mammary Cancer. (Letter to the Editor.) Cancer Investigation, Vol. 7, 1989, 301-302.

51. Augsburger JJ, Gamel JW, Shields JA. Cobalt Plaque Radiotherapy Versus Enucleation For Posterior Uveal Melanoma: Comparison of Survival By Prognostic Index Groups. Tr Am Ophth Soc, Vol. 87, 1989: 348-359.

52. Augsburger JJ, Schroeder RP, Territo C, Gamel JW, Shields JA. Clinical Parameters Predictive of Enlargement of Melanocytic Choroidal Lesions. Br J Ophthalmol, Vol. 73, 1989: 911-917.

53. Huntington A, Haugan P, Gamel JW, McLean I. A Simple Cytologic Method for Predicting the Malignant Potential of Intraocular Melanoma. Path Res Pract, Vol. 185, 1989: 631-634.

54. McMillan J, Char DH, McLean IW, Gamel JW. DNA Content Analysis of Uveal Melanoma. Arch Ophthalmol, Vol. 107, 1989: 1278-10.

55. Augsburger JJ, Gamel JW, Lauritzen K, Brady LW. Cobalt-60 Plaque Radiotherapy vs Enucleation For Posterior Uveal Melanoma. Am J Ophthalmol, Vol. 109, 1990: 585-592.

56. Gamel, JW, McLean, IW, Rosenberg, SH. Proportion Cured and Mean Log Survival Time As Functions of Tumour Size. Statistics In Medicine, Vol. 9, 1990: 999-1006.

57. Augsburger JJ, Lauritzen K, Gamel JW, Lowry JC, Brady LW. Matched Group Study of Pre-enucleation Radiotherapy Versus Enucleation Alone for Primary Malignant Melanoma of the Choroid and Ciliary Body. Am J Clin Oncol,(CCT), Vol. 13, 1990: 382-387. 

58. Augsburger, JJ, Lauritzen K, Gamel JW, DeBrakeleer DJ, Lowry JC, Eisenman R. Matched Group Study of Surgical Resection Versus Cobalt-60 Plaque Radiotherapy for Primary Choroidal or Ciliary Body Melanoma. Ophthalmic Surgery, Vol 21, 1990: 682-688.

59. Augsburger JJ, Gamel JW. Clinical Prognostic Factors in Patients With Posterior Uveal Malignant Melanoma. Cancer, Vol 66, 1990: 1596-1600.

60. McLean IW, Berd D, Mastrangelo MJ, Shields JA, Davidorf FH, Grever M, Makley TA, Gamel JW. A Randomized Study of Methanol-Extraction Residue of Bacille Calmette-Guerin as Postsurgical Adjuvant Therapy of Uveal Melanoma. American Journal of Ophthalmology, Vol 110, 1990: 522-526.

61. Vrabec TR, Augsburger JJ, Gamel JW, Brady LW, Hernandez C, Woodleigh R. Impact of Local Tumor Relapse Following Cobalt-60 Plaque Radiotherapy on Patient Survival. American Journal of Ophthalmology, Vol. 98, 1991: 984-988.

62. Gamel JW, Axelrod DE. Inheritance and Regression Toward the Mean In Heterogeneous Cell Populations. Cell Prolif, Vol. 24, 1991: 281-292.

63. McCurdy JB, Gamel JW, McLean IW. A Simple, Efficient, and Reproducible Method for Estimating the Malignant Potential of Uveal Melanoma From Routine H&E Slides. Path. Res. Pract, Vol. 187, 1991: 1025-1027.

64. Medlock RD, Augsburger JJ, Wilkinson CP, Cox MS, Gamel JW, Nicholl, J. Enlargement of Circumscribed Choroidal Hemangiomas. Retina, Vol. 11, 1991: 385-388.

65. Burnier MN, Jr, McLean IW, Gamel JW. Immunohistochemical Evaluation of Uveal Melanocytic Tumors: Expression of HMB-45, S-100 Protein, and Neuron-Specific Enolase. Cancer, Vol. 68, 1991: 809-814.

66. Wilson MC, Barr CC, Gamel JW, Cyrus J, Lynch TN. Evaluation of the Tourniquet Test as a Predictor of Diabetic Retinopathy. J. Diabet Complications, Vol. 5, 1991: 221-224.

67. Gamel JW. Fever in the Night. (Letter to the Editor). Arch Ophthalmol, Vol. 109, 1991: 911-912.

68. Augsburger JJ, Gamel JW. The risk of major audiovisual problems during ophthalmic presentations. Survey Ophthalmol, Vol. 36, 1992: 390-2.

69. Sanborn GE, Niederkorn JY, Gamel JW. Efficacy of Dacarbazine (DTIC) In Preventing Metastases Arising From Intraocular Melanomas In Mice. Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 230, 1992: 192-196.

70. Gamel JW, McCurdy JB, McLean IW. A Comparison of Prognostic Covariates For Uveal Melanoma. Investigative Ophthalmology & Visual Science, Vol. 33, 1992: 1919-1922.

71. Gamel JW, Barr CC. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. (Letter to Editor). Arch Ophthalmol, Vol. 111, 1993: 1462-3.

72. Gamel JW, McLean IW, McCurdy JB. Biologic Distinctions Between Cure and Time To Death in 2892 Patients with Intraocular Melanoma. Cancer, Vol. 71, 1993: 2299- 2305.

73. Gamel JW, Jones AS. Squamous Carcinoma of the Head and Neck: Cured Fraction and Median Survival Time as Functions of Age, Sex, Histologic Type, and Node Status. Br. J. Cancer, Vol. 67, 1993: 1071-1075.

74. Sorensen FB, Gamel JW, McCurdy JB. Stereologic Estimation of Nucleolar Volume in Ocular Melanoma: A Comparative Study of Size Estimators With Prognostic Impact. Human Pathology, Vol. 24, 1993: 513-518.

75. Gamel JW, Vogel RL, McLean IW. Assessing the Impact of Adjuvant Therapy on Cure Rate for Stage 2 Breast Carcinoma. Br J Cancer, Vol. 68, 1993: 115-118.

76. Gamel JW, Vogel RL. A Model of Long-term Survival Following Adjuvant Therapy for Stage 2 Breast Cancer. Br J Cancer, Vol. 68, 1993: 1167-1170.

77. Sorensen FB, Gamel JW, Jensen OA, Ladekari M, McCurdy JB. Prognostic Value of Nucleolar Size and Size Pleomorphism in Choroidal Melanomas. APMIS, Vol. 101, 1993: 358-368.

78. Gamel JW, George SL, Stanley WE, Seigler HF. Skin Melanoma: Cured Fraction and Survival Time as Functions of Thickness, Site, Histologic Type, Age and Sex. Cancer, Vol. 72, 1993: 1219-1223.

79. Gamel JW, McLean IW. A Stable, Multivariate Extension of the Lognormal Survival Model. Computers and Biomedical Research, Vol. 27, 1994: 148-155.

80. Reyes ME, Barr CC, Gamel JW. Blood Levels in Macular Cystoid Spaces and Their Relationship to Retinal Vein Obstruction. Retina, Vol. 14, 1994: 14-18.

81. Gamel JW, Vogel RL, Valagussa P, Bonadonna G. Parametric Survival Analysis of Adjuvant Therapy for Stage II Breast Cancer. Cancer, Vol. 74, 1994: 2483-2490.

82. McLean IW, Ainbinder DJ, Gamel JW, McCurdy JB. Choroidal-Ciliary Body Melanoma: A Multivariate Survival Analysis of Tumor Location. Ophthalmology, Vol. 102, 1995: 1060-1064.

83. Gamel JW, Meyer JS, Province MA. Proliferative Rate by S-Phase Measurement May Affect Cure of Breast Carcinoma. Cancer, Vol. 76, 1995: 1009-18.

84. Gamel JW, Meyer JS, Feuer E, Miller BA. The Impact of Stage and Histology on the Long-Term Clinical Course of 163,808 Patients With Breast Carcinoma. Cancer, Vol. 77, 1996: 1458-64.

85. Gamel JW, Edwards MJ. Parametric Models of Therapeutic Efficacy in Breast Cancer. Letter to the Editor - The New England Journal of Medicine, Vol 334, 1996: 1270-1271.

86. Axelrod DE,Gusev Y, Gamel JW. Ras Oncogene-Transformed and Non-Transformed Cell Populations Are Each Heterogeneous But Respond Differently To the Chemotherapeutic Drug Cytosine Arabinoside (Ara-C). Cancer Chemother Pharmacol, Vol. 39, 1997: 445-451.

87. Gamel JW, Vogel RL. Comparison of Parametric and Non-parametric Survival Methods Using Simulated Clinical Data. Statistics in Medicine, Vol. 16, 1997: 1629-1643.

88. Edwards MJ, Gamel JW. Improvement in the Prognosis of Breast Cancer from 1965 to 1984. J Clin Oncology, Vol. 16, 1998: 1030-1035.

89. Edwards MJ, Gamel JW, Vaughan WP, Wrightson WR. Infiltrating Ductal Carcinoma of the Breast: The survival impact of Race. J Clin Oncology, Vol. 16, 1998: 1-8.

90. Edwards MJ, Bonadonna G, Valagussa P, Gamel JW. End Points in the Analysis of Breast Cancer Survival: Relapse versus Death From Tumor. Surgery, Vol. 124, 1998: 197-202.

91. McLean IW, Gamel JW. Cause-specific versus All-cause Survival. Ophthalmology, Vol 105, 1998: 1989-1990.

92. Gamel JW. Retinal vascular occlusion and deficiencies in the protein C pathway. (Letter to Editor) Am J Ophthalmol, Vol. 129, 2000: 112-3.

93. Gamel JW, Weller EA, Wesley MN, Feuer EJ. Parametric Cure Models of Relative and Cause-specific Survival for Grouped Survival Times. Computer Methods and Programs in Biomedicine, Vol. 61, 2000: 99-110.

94. Gamel JW, Vogel RL. Non-prametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients. Statistical Methods in Medical Research, 200, 1Vol 10: 339-352.

95. Gamel J. Occurrence of retinoblastoma and uveal melanoma in the same period. (Letter to editor). Retina, Vol. 21, 2001: 94-95.